Echo Energy Plc (LON:ECHO) told investors that it has hired a contractor for the reprocessing of 3D seismic for the Huayco and Rio Salado blocks, onshore Bolivia. The contract was awarded to DMT Petrologic which, according to Echo, has extensive experience in the reprocessing of vintage data in similar thrust belt areas.
Mosman Oil And Gas Ltd (LON:MSMN) confirmed it has now completed the deal for the Welch Permian basin project marking its second acquisition in the last quarter. It added that other potential acquisitions are under review, but, the immediate focus is on its new projects.
Asiamet Resources Limited (LON:ARS) expects to complete a feasibility study for its Beruang Kanan Main zone (BKM) early next year, with a development decision thereafter. In the six months to end June, Asiamet posted a net loss of $2.014mln against a loss of $808,000 a year earlier - the increase mainly relating to ongoing feasibility work at BKM and exploration and advancing the mining license at the Beutong project to production from exploration.
Premier African Minerals Limited (LON:PREM) has increased the estimate of the amount of tungsten in the underground section of its RHA project in Zimbabwe. The company said in a statement that measured resources rise 32% to 0.029m tonnes with a 52% increase in grade to 5.45kg WO3 (tungsten trioxide) per tonne.
SDX Energy Inc (LON:SDX, CVE:SDX) has confirmed the completion of its US$10mln equity placing which aims to fund an acceleration of new drilling plans in Egypt and Morocco. New shares were issued at 43.75p, which was the mid-market price immediately before the placing was announced earlier this month.
Green Dragon Gas Ltd (LON:GDG) is poised to add 6.36Bcf (billion cubic feet) to its output per year after it received approval for the Greka Chengzhuang Block (GCZ). The green light from the state means the firm can begin what's called the overall development plan (ODP) on the acreage.
Share in Motif Bio Plc (LON:MTFB) rose 6% after it confirmed the US Food & Drug Administration had granted its lead drug orphan designation. This status, which qualifies the antibiotic iclaprim for certain incentives including tax breaks, is for a very narrow indication: the treatment of cystic fibrosis patients with Staphylococcus aureus lung infections.
APQ Global Limited (LON:APQ), the emerging markets growth investor announced that, as at the close of business on 31 August 2017, its unaudited book value per was 96.49p per ordinary share.
Rosslyn Data Technologies PLC (LON: RDT) has granted a total of 13,866,670 options to subscribe for new ordinary shares to various employees and directors of the company. The cloud-based enterprise data analytics platform group said the options are split into three equal tranches and each tranche shall vest evenly over a 3 year period. It added that the options are exercisable at 5.625p and will expire on 1 September 2027.